Deciding on treatment for advanced cancer is overwhelming on your own.

Cancer Commons provides compassionate support as we identify and help you access the best diagnostic and treatment options.

We are unbiased and patient-centric. Our priority is you.

Over 10 years, we have helped thousands of advanced and metastatic cancer patients and caregivers with one-on-one support.

Our expert team is passionate about helping you find and understand your options. Together we will create a personalized plan of action you can share with your oncologist.

  • Cancer Commons CEO Rebecca Driscoll. smiling
    Get to Know Rebecca Driscoll, CEO of Cancer Commons

    When asked how she spends her free time, Rebecca Driscoll says she thinks about cancer pretty much twenty-four hours per day, seven days per week. While she may also love to cook, design floral arrangements for events, and create jewelry, Rebecca’s fierce dedication to helping people with cancer is immediately evident to anyone who encounters her. Rebecca joined Cancer Commons as CEO in July… Read more »

  • Cancer Commons logo next to the word WEBINAR, over the title of the webinar: A New Technology for Rapid Therapy Guidance
    A New Technology for Rapid Therapy Guidance: Webinar Recording Now Available

    Cancer Commons’ most recent webinar, A New Technology for Rapid Therapy Guidance, was held virtually December 14, 2022. This presentation and Q&A session introduced viewers to a new cancer therapy guidance test that is designed to predict which cancer drugs are most likely to be effective for individual cancer patients. Cancer Commons CEO Rebecca Driscoll introduced Clifford Reid, PhD (Founder and CEO) and Dennis Watson (VP… Read more »

  • Webinar Invitation. A New Technology for Rapid Therapy Guidance. December 14, 2022. 12 noon Pacific. Free Webinar sponsored by Travera. Cancer Commons logo over REGISTER NOW.
    Cancer Commons Presents Free Webinar: A New Technology for Rapid Therapy Guidance

    We invite everyone to join us to learn about a cancer therapy guidance test designed to predict which cancer drugs are most likely to be effective for individual cancer patients. Cancer Commons is partnering with Travera with the shared goal of helping late-stage cancer patients who are running out of therapeutic options and time. A New Technology for Rapid Therapy Guidance will be held December 14,… Read more »

  • Cancer Commons has been exceptional. My family and I could not be happier with the attention and passion that this organization has shown towards us. Thank you for being so responsive and reassuring us that there is so much hope.

    Larry Simmons
    Pancreatic cancer patient

  • The team at Cancer Commons created a very thorough and clear report which is extremely helpful! It is evident they took the time to read my father’s medical history and suggest a personalized plan for his condition. Matt was extremely kind and supportive during this difficult time. Thank you!

    Daughter of a glioblastoma patient

  • Your personal and caring outreach, response, and approach were heartwarming during this difficult time. Recommendations and report were professional and very insightful. I felt as if a caring family member was with us. I cannot stress enough how supportive that feeling is. Thank you!


  • Cancer Commons is extremely engaged and proactive. Its professionals have directed us towards interesting avenues to explore in our search for additional treatment options.

    Spouse of stage IV ovarian cancer victim

  • I learned more about my trial options from Emma in a week than I did in 3 years of previous care. Every metastatic patient should know about Cancer Commons. And I love how they use the data to speed up the N-of-1 success stories.

    Michelle Kendall
    Cancer Patient